GlassScriptPhysician profile
Laura Glass
NPI 1114786845
$1,909.30
in general payments reported to CMS, 2019-2025
17 companies · $1,205 in 2025
The $1,205 reported for 2025 was more than what 84% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $705 · 2025: $1,205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,882 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,882.03 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $353.21 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $284.28 | 2024-2025 | Trintellix |
| Axsome Therapeutics, INC. | $250.79 | 2024-2025 | Auvelity |
| Supernus Pharmaceuticals, INC. | $154.64 | 2024-2025 | Qelbree |
| Noven Therapeutics, LLC | $136.71 | 2024-2025 | Xelstrym, Secuado |
| Otsuka America Pharmaceutical, INC. | $132.04 | 2024-2025 | Rexulti |
| Lundbeck LLC | $91.55 | 2024-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $83.71 | 2024-2025 | Fanapt, Hetlioz |
| E.R. Squibb & Sons, L.L.C. | $80.70 | 2024-2025 | Cobenfy |
| Collegium Pharmaceutical, INC. | $77.37 | 2025 | Jornay Pm |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $75.71 | 2024-2025 | Caplyta |
| Alkermes, INC. | $44.31 | 2025 | Aristada, Lybalvi |
| Neos Therapeutics, LP | $38.13 | 2024-2025 | Adzenys Xr-Odt |
| Novo Nordisk INC | $35.86 | 2024-2025 | Wegovy |
| Corium, LLC | $31.44 | 2024-2025 | Azstarys |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $21.86 | 2024 | |
| Janssen Pharmaceuticals, INC | $16.99 | 2025 | Invega Sustenna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Glass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.